| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,036 |
21,453 |
$938K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,665 |
2,573 |
$204K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,130 |
2,056 |
$170K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,523 |
1,453 |
$116K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,251 |
1,146 |
$65K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
800 |
771 |
$62K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,636 |
6,204 |
$49K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,108 |
974 |
$35K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,773 |
3,541 |
$22K |
| 99381 |
|
242 |
204 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,508 |
2,295 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,554 |
1,244 |
$14K |
| 92551 |
|
2,628 |
2,446 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,288 |
1,216 |
$7K |
| 90670 |
|
1,535 |
1,457 |
$6K |
| 99051 |
|
1,070 |
984 |
$4K |
| 90686 |
|
1,278 |
1,258 |
$3K |
| 69210 |
|
470 |
436 |
$3K |
| 90744 |
|
602 |
558 |
$3K |
| 90698 |
|
1,019 |
953 |
$2K |
| 90707 |
|
516 |
492 |
$2K |
| 90633 |
|
584 |
552 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
180 |
164 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
14 |
$1K |
| 81002 |
|
796 |
718 |
$1K |
| 99172 |
|
1,008 |
929 |
$840.45 |
| 90716 |
|
527 |
503 |
$775.92 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
276 |
245 |
$686.69 |
| 96127 |
|
820 |
767 |
$616.56 |
| 90680 |
|
838 |
780 |
$395.88 |
| 90700 |
|
58 |
57 |
$330.00 |
| 90621 |
|
38 |
32 |
$302.09 |
| 90619 |
|
16 |
15 |
$258.22 |
| 85018 |
|
190 |
184 |
$180.61 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
593 |
566 |
$148.99 |
| 90651 |
|
218 |
214 |
$65.88 |
| 90734 |
|
170 |
157 |
$50.00 |
| 90685 |
|
53 |
52 |
$10.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
48 |
44 |
$0.00 |
| 90696 |
|
31 |
30 |
$0.00 |
| 99173 |
|
89 |
86 |
$0.00 |
| 90715 |
|
94 |
92 |
$0.00 |
| 90461 |
|
15 |
14 |
$0.00 |
| 90648 |
|
25 |
25 |
$0.00 |